Celcuity (CELC) Change in Interest Receivables (2018 - 2019)
Celcuity's (CELC) quarterly Change in Interest Receivables came in at -$7963.0 in Q1 2019, down 133.3% YoY from $23912.0 in Q1 2018, and down 133.3% on a QoQ basis from $23912.0 in Q1 2018.
Powered by 
Analysis
Celcuity (CELC) Change in Interest Receivables (2018 - 2019) Analysis & Trends
Celcuity (CELC) has 2 years of Change in Interest Receivables data on file, last reported at -$7963.0 in Q1 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Interest Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Celcuity | 5.25 Bn | 5.25 Bn | - | - |